Research
Compare
Two to six companies, their latest annual figures side by side, from SEC filings.
APVOAptevo Therapeutics Inc.
| Figure | APVOAptevo Therapeutics Inc.FY2022 · Dec |
|---|---|
| Revenue | $3.11M |
| Revenue, yoy | −74.7% |
| Net income | $25.97M |
| Net income, yoy | −7.6% |
| Net margin | — |
| Free cash flow | $21.05M |
| FCF margin | -676.0% |
| EPS, diluted | $87.27 |
Add another company.
Annual · FY2018–FY2022 · USD
From SEC EDGARSame fiscal periods, as filed